Inspection Record

Rancho Park Compounding Pharmacy — FDA 483 Findings

US FDAInspected 2019-05-07Published 2019-07-25 9 findingsAseptic processing and sterility assuranceContamination controlEnvironmental monitoringEquipment and facilityTraining and personnel

Inspectors Taichun QinThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Materials or supplies were not disinfected prior to entering the aseptic processing areas.

3Aseptic processing and sterility assurance

The ISO 5 classified aseptic processing areas had visibly dirty equipment or surface.

4Environmental monitoring

Unsealed, loose ceiling tiles were observed in your cleanroom.

5Aseptic processing and sterility assurance

The segregated production areas sunounding the ISO 5 classified aseptic processing area contained dust-collecting overhangs without adequate and frequent cleaning.

6Equipment and facility

Your facility was designed and/or operated in a way that permits poor flow of personnel and materials.

7Aseptic processing and sterility assurance

Disinfecting agents and cleaning wipes used in the ISO 5 classified aseptic processing areas were not sterile.

8Training and personnel

Personnel donned gowning apparel improperly, in a way that may have caused the gowning apparel to become contaminated.

9Aseptic processing and sterility assurance

Personnel conducted aseptic manipulations and placed equipment/supplies in an area that blocked the movement offirst pass air around an open unit, either before or after it was filled with sterile product.

About this record

Extracted automatically from the document US FDA published on 2019-07-25. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Rancho Park Compounding Pharmacy company profile — full historyAll US FDA findings US FDA documents, 2019 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.